Sort
130,381 grants matching “hiv”
PS10-10138, EXPANDED HIV TESTING FOR DISPROPORTIONATELY AFFECTED POPULATIONS
$1,221,112Mildred Williamson · Illinois State Dept Of Public Health · U62 · FY2010 · PS
PRESCIENT: A phase IIc, open-label, randomized controlled trial of ultra-short course bedaquiline, clofazimine, pyrazinamide and delamanid versus standard therapy for drug-susceptible tuberculosis
$1,221,014Serena Patricia Koenig · Brigham And Women'S Hospital · U01 · FY2022 · AI
NOVEL HIV VACCINES
$1,220,773University Of Md Biotechnology Institute · P01 · FY2002 · AI
Emory HIV/AIDS Clinical Trials Unit
$1,220,731Jeffrey Lennox · Emory University · U01 · FY2007 · AI
STRUCTURAL BIOLOGY AND TARGETED DRUG DESIGN FOR AIDS
$1,220,651University Of California San Francisco · P01 · FY2001 · GM
Theoretically Informed Behavioral Intervention to Enhance QOL and Prevent HIV-related Comorbidities
$1,220,442Silvia Raquel Ramos · Yale University · R01 · FY2025 · MD
Simplifying PrEP delivery: One-stop service pathway to improve PrEP care efficiency and continuation in Kenya
$1,220,378Kenneth Kiggundu Mugwanya · University Of Washington · RF1 · FY2025 · MH
The Impact of Early Medical Treatment in Transgender Youth
$1,220,340Johanna L Olson-Kennedy · Children'S Hospital Of Los Angeles · R01 · FY2016 · HD
EXPANDED & INTEGRATED HUMAN IMMUNODEFICIENCY VIRUS (HIV) TESTING FOR POPULATIONS
$1,219,811John Cella · Philadelphia Departmentof Public Health · U62 · FY2008 · PS
Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir
$1,219,661Rafick-Pierre Sekaly · Emory University · P01 · FY2024 · AI
Development of strategies to achieve immunoprotection against Cryptosporidiosis
$1,219,632Saul R Tzipori · University Of Maryland Baltimore · U19 · FY2015 · AI
Research Capacity Core
$1,219,627Abiel Roche-Lima · University Of Puerto Rico Med Sciences · U54 · FY2025 · MD
NEUROCOGNITIVE FUNCTION, HIV LOAD AND SURROGATE MARKERS
$1,219,444Children'S Memorial Hospital (Chicago) · P01 · FY2001 · NS
Identification of the Initial Targets of Transmission
$1,219,391Thomas Hope · Northwestern University At Chicago · R01 · FY2013 · AI
NorthStar Node of the Clinical Trials Network
$1,219,146Gavin Bart · Hennepin Healthcare Research Institute · UG1 · FY2019 · DA
Drug Resistance Genotypic and Phenotypic Correlates of Efavirenz and Dolutegravir based Treatment Outcomes across Non-B HIV-1 subtypes
$1,219,140Lisa M Frenkel · Seattle Children'S Hospital · R01 · FY2022 · AI
UWC: HUMAN-CAPACITY DEVELOPMENT TO ADDRESS HIV/AIDS IN SOUTH AFRICA (UWC HCD-HIV-
$1,219,130David Sanders · University Of The Western Cape · U2G · FY2009 · PS
UWC: HUMAN-CAPACITY DEVELOPMENT TO ADDRESS HIV/AIDS IN SOUTH AFRICA (UWC HCD-HIV-
$1,219,130David Sanders · University Of The Western Cape · U2G · FY2010 · PS
Pediatric Clinical Trials Program for AIDS
$1,219,019Baylor College Of Medicine · U01 · FY2002 · AI
Integrating HIV and hEART health in South Africa (iHeart-SA)
$1,218,970Francois Venter · Wits Health Consortium (Pty), Ltd · UH3 · FY2024 · HL
Gene-Environment Interplay in the Development of Drug Abuse, HIV Sexual Risk Beha
$1,218,922Karl Gordon Hill · University Of Washington · R01 · FY2012 · DA
Women's Interagency HIV Study (WIHS-V)
$1,218,689Kathryn M Anastos · Albert Einstein College Of Medicine, Inc · U01 · FY2015 · AI
Immunopathogenesis of HIV Neurological Disorders
$1,218,628University Of Puerto Rico Med Sciences · U54 · FY2003 · NS
SUSTAINING ABSTINENCE IN DUALLY DIAGNOSED HOMELESS
$1,218,625University Of Alabama At Birmingham · R01 · FY2000 · DA
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)
$1,218,576Adam Wayne Carrico · University Of Miami School Of Medicine · R01 · FY2021 · MH